509 related articles for article (PubMed ID: 33112646)
1. Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study.
Suehs CM; Menzies-Gow A; Price D; Bleecker ER; Canonica GW; Gurnell M; Bourdin A;
Am J Respir Crit Care Med; 2021 Apr; 203(7):871-881. PubMed ID: 33112646
[No Abstract] [Full Text] [Related]
2. Expert consensus on oral corticosteroids stewardship for the treatment of severe asthma in the Middle East and Africa.
Al-Ahmad M; Al Zaabi A; Madkour A; Alqaraghuli HA; Al Hayaan H; Mobayed H; Idrees M; Al Busaidi N; Zeineldine S
Respir Med; 2024 Jul; 228():107674. PubMed ID: 38782138
[TBL] [Abstract][Full Text] [Related]
3. Reducing oral corticosteroids in severe asthma (ROSA Project): a nationwide Portuguese consensus.
Chaves Loureiro C; Branco Ferreira M; Ferreira J; Lima R; Marques J; Sokolova A; Tonin FS; Duarte Ramos F
Pulmonology; 2021; 27(4):313-327. PubMed ID: 33177008
[TBL] [Abstract][Full Text] [Related]
4. Long-term corticosteroid use, adrenal insufficiency and the need for steroid-sparing treatment in adult severe asthma.
Gurnell M; Heaney LG; Price D; Menzies-Gow A
J Intern Med; 2021 Aug; 290(2):240-256. PubMed ID: 33598993
[TBL] [Abstract][Full Text] [Related]
5. [Use of systemic glucocorticoids for the treatment of severe asthma: Spanish Multidisciplinary Consensus].
Domínguez-Ortega J; Delgado Romero J; Muñoz Gall X; Marco A; Blanco-Aparicio M
Open Respir Arch; 2022; 4(4):100202. PubMed ID: 37496970
[TBL] [Abstract][Full Text] [Related]
6. Measures to reduce maintenance therapy with oral corticosteroid in adults with severe asthma.
Nguyen VQ; Ulrik CS
Allergy Asthma Proc; 2016 Nov; 37(6):125-139. PubMed ID: 27931289
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study.
Schutt AC; Bullington WM; Judson MA
Respir Med; 2010 May; 104(5):717-23. PubMed ID: 20089389
[TBL] [Abstract][Full Text] [Related]
8. Development of an operational definition of treatment escalation in adults with asthma adapted to healthcare administrative databases: A Delphi study.
Yousif A; Forget A; Beauchesne MF; Lemière C; Dugré N; Fénélon-Dimanche R; Blais L
Respir Med; 2021; 185():106510. PubMed ID: 34182265
[TBL] [Abstract][Full Text] [Related]
9. Oral Corticosteroid Use for the Treatment of Chronic Eosinophilic Disease: A Patient's and His Physician's Experience.
Silva M; Roufosse F
Adv Ther; 2019 Oct; 36(10):2558-2566. PubMed ID: 31473972
[TBL] [Abstract][Full Text] [Related]
10. Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process.
Kardos P; Bechtel B; Palovis L; Hagedorn C; Latif F
Pneumologie; 2012 Sep; 66(9):549-57. PubMed ID: 22899206
[TBL] [Abstract][Full Text] [Related]
11. Rational oral corticosteroid use in adult severe asthma: A narrative review.
Chung LP; Upham JW; Bardin PG; Hew M
Respirology; 2020 Feb; 25(2):161-172. PubMed ID: 31713955
[TBL] [Abstract][Full Text] [Related]
12. Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations.
Carpenedo M; Baldacci E; Baratè C; Borchiellini A; Buccisano F; Calvaruso G; Chiurazzi F; Fattizzo B; Giuffrida G; Rossi E; Palandri F; Scalzulli PR; Siragusa SM; Vitucci A; Zaja F
Ther Adv Hematol; 2021; 12():20406207211048361. PubMed ID: 34646432
[TBL] [Abstract][Full Text] [Related]
13. "Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease": a consensus document.
Alcázar Navarrete B; Casanova C; Miravitlles M; de Lucas P; Riesco JA; Rodríguez González-Moro JM;
Arch Bronconeumol; 2015 Apr; 51(4):193-8. PubMed ID: 25540900
[TBL] [Abstract][Full Text] [Related]
14. Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis.
Prazma CM; Bel EH; Price RG; Bradford ES; Albers FC; Yancey SW
Respir Res; 2019 May; 20(1):83. PubMed ID: 31053134
[TBL] [Abstract][Full Text] [Related]
15. Perception of oral corticosteroids in adult patients with asthma in France.
Jaffuel D; Fabry-Vendrand C; Darnal E; Wilczynski O; Pain E; Bourdin A
J Asthma; 2021 Jul; 58(7):946-957. PubMed ID: 32285714
[TBL] [Abstract][Full Text] [Related]
16. Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry.
Graff S; Vanwynsberghe S; Brusselle G; Hanon S; Sohy C; Dupont LJ; Peche R; Michils A; Pilette C; Joos G; Louis RE; Schleich FN
Respir Res; 2020 Aug; 21(1):214. PubMed ID: 32787967
[TBL] [Abstract][Full Text] [Related]
17. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature.
Volmer T; Effenberger T; Trautner C; Buhl R
Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30190274
[TBL] [Abstract][Full Text] [Related]
18. Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study.
Mattei L; Suehs CM; Alagha K; Bourdin A; Brousse C; Charriot J; Devouassoux G; Fry S; Guilleminault L; Gouitaa M; Taille C; Chanez P; Pahus L
Ther Adv Respir Dis; 2021; 15():17534666211049735. PubMed ID: 34629000
[TBL] [Abstract][Full Text] [Related]
19. Oral corticosteroid-dependent asthma: current knowledge and future needs.
Pavord ID
Curr Opin Pulm Med; 2019 Jan; 25(1):51-58. PubMed ID: 30461530
[TBL] [Abstract][Full Text] [Related]
20. Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma.
Korn S; Howarth P; Smith SG; Price RG; Yancey SW; Prazma CM; Bel EH
Respir Res; 2022 Mar; 23(1):45. PubMed ID: 35246123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
